Vaxart

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vaxart and other ETFs, options, and stocks.

About VXRT

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. 

CEO
Andrei Floroiu
CEOAndrei Floroiu
Employees
125
Employees125
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2004
Founded2004
Employees
125
Employees125

VXRT Key Statistics

Market cap
168.00M
Market cap168.00M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
2.68M
Average volume2.68M
High today
$1.35
High today$1.35
Low today
$1.27
Low today$1.27
Open price
$1.31
Open price$1.31
Volume
993.80K
Volume993.80K
52 Week high
$8.13
52 Week high$8.13
52 Week low
$1.26
52 Week low$1.26

VXRT News

Benzinga 6d
Vaxart to Present at World Vaccine & Immunotherapy Congress West Coast 2022 on November 29 - Vaxart (NASD - Benzinga

SOUTH SAN FRANCISCO, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. VXRT today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, wil...

Vaxart to Present at World Vaccine & Immunotherapy Congress West Coast 2022 on November 29 - Vaxart (NASD - Benzinga

VXRT Earnings

-$0.24
-$0.16
-$0.08
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, After Hours
ActualExpected Feb 23, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.